drugset / Trial / NCT00642187

New Version Pulmicort Turbuhaler USA Adults

NCT00642187 ↗

Phase 3 Completed 525 enrolled AstraZeneca
RandomizedParallel-groupSingle-blindTreatment

Summary

A comparison of the safety, efficacy and budesonide pharmacokinetics of the currently approved Pulmicort Turbuhaler with a new version of the inhaler, in adult patients who have asthma and are currently being treated with inhaled steroids. In addition the study evaluated the functionality of the new inhaler at the end of its intended life.

Timeline

Start
2002-07
Primary completion
2004-10
Completion
2004-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Budesonide Small molecule — Inhaled

Indications